ERBB2 and breast cancer: TNBC refers to a subtype of breast cancer that lacks ER, PR, and HER2, which accounts for 15%-20% of breast cancer cases, and more than 50% of patients recur within the first 3-5 years after diagnosis, making it the most malignant subtype of breast cancer (95, 96).